JP2009269923A5 - - Google Patents

Download PDF

Info

Publication number
JP2009269923A5
JP2009269923A5 JP2009185305A JP2009185305A JP2009269923A5 JP 2009269923 A5 JP2009269923 A5 JP 2009269923A5 JP 2009185305 A JP2009185305 A JP 2009185305A JP 2009185305 A JP2009185305 A JP 2009185305A JP 2009269923 A5 JP2009269923 A5 JP 2009269923A5
Authority
JP
Japan
Prior art keywords
pharmaceutical formulation
formulation
unit dose
less
tobramycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009185305A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009269923A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2009269923A publication Critical patent/JP2009269923A/ja
Publication of JP2009269923A5 publication Critical patent/JP2009269923A5/ja
Pending legal-status Critical Current

Links

JP2009185305A 2001-05-18 2009-08-07 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物 Pending JP2009269923A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29223401P 2001-05-18 2001-05-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002590936A Division JP2004534763A (ja) 2001-05-18 2002-05-17 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物

Publications (2)

Publication Number Publication Date
JP2009269923A JP2009269923A (ja) 2009-11-19
JP2009269923A5 true JP2009269923A5 (enExample) 2010-09-02

Family

ID=23123791

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002590936A Pending JP2004534763A (ja) 2001-05-18 2002-05-17 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物
JP2009185305A Pending JP2009269923A (ja) 2001-05-18 2009-08-07 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002590936A Pending JP2004534763A (ja) 2001-05-18 2002-05-17 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物

Country Status (11)

Country Link
US (8) US20030143162A1 (enExample)
EP (2) EP1320355B1 (enExample)
JP (2) JP2004534763A (enExample)
AT (1) ATE322249T1 (enExample)
AU (1) AU2010210026A1 (enExample)
CA (1) CA2447600C (enExample)
DE (1) DE60210402T2 (enExample)
DK (1) DK1320355T3 (enExample)
ES (1) ES2261735T3 (enExample)
PT (1) PT1320355E (enExample)
WO (1) WO2002094217A1 (enExample)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
US20030143162A1 (en) * 2001-05-18 2003-07-31 Speirs Robert John Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
US20040022740A1 (en) * 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
CA2456746A1 (en) * 2001-08-20 2003-02-27 Transave, Inc. Method for treating lung cancers
JP2005514393A (ja) * 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
US8245708B2 (en) * 2002-05-07 2012-08-21 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
US7607436B2 (en) * 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
AU2003302314A1 (en) * 2002-08-02 2004-07-09 Transave, Inc. Platinum aggregates and process for producing the same
US9186322B2 (en) * 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
AU2002953095A0 (en) * 2002-11-29 2002-12-19 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
EP3738591A3 (en) * 2003-03-10 2021-03-24 Merck Sharp & Dohme Corp. Novel antibacterial agents
NZ546821A (en) * 2003-10-15 2009-04-30 Pari Pharma Gmbh Liquid preparation containing tobramycin
CA2559722A1 (en) * 2004-03-18 2005-09-29 Transave, Inc. Administration of cisplatin by inhalation
US20070065522A1 (en) * 2004-03-18 2007-03-22 Transave, Inc. Administration of high potency platinum compound formulations by inhalation
SI2316419T1 (sl) 2004-05-17 2012-10-30 Gilead Sciences Inc Aerosolna kombinacija fosfomicina/tobramicina za zdravljenje bakterijskih respiratornih infekcij
WO2005112957A1 (en) * 2004-05-21 2005-12-01 Transave, Inc. Treatment of lung diseases and pre-lung disease conditions
WO2006002178A1 (en) 2004-06-18 2006-01-05 Novartis Vaccines And Diagnostics Inc. Methods of treatment of endobronchial infections
JP5735724B2 (ja) * 2004-11-08 2015-06-17 インスメッド， インコーポレイテッド 腹腔内投与される脂質ベースの白金化合物製剤を用いた、癌の治療方法
AU2013206401B2 (en) * 2005-09-29 2016-06-23 Novartis Ag Antibiotic formulations, unit doses, kits, and methods
CN101287446A (zh) * 2005-09-29 2008-10-15 尼克塔治疗公司 抗生素制剂、单位剂量、试剂盒以及方法
US20070190180A1 (en) * 2005-11-08 2007-08-16 Pilkiewicz Frank G Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
WO2007056236A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
US20070190182A1 (en) * 2005-11-08 2007-08-16 Pilkiewicz Frank G Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
US20070122350A1 (en) * 2005-11-30 2007-05-31 Transave, Inc. Safe and effective methods of administering therapeutic agents
ES2798263T3 (es) 2005-12-08 2020-12-10 Insmed Inc Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
US8337814B2 (en) * 2005-12-15 2012-12-25 Topical Sinus Therapeutics, Inc. Treatment of active infections, sinusitis, rhinitis, and related neurological disorders and related compositions
JP2008199905A (ja) * 2007-02-16 2008-09-04 Snow Brand Milk Prod Co Ltd 乳酸菌生残性向上剤
CN101917850B (zh) 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
EP2260510A1 (en) * 2008-04-02 2010-12-15 Nxp B.V. Method of manufacturing a semiconductor device and semiconductor device
DK2358379T3 (en) * 2008-10-24 2016-03-07 Cempra Pharmaceuticals Inc BIOFORSVAR USING TRIAZOLHOLDIGE macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (en) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
BR112012023950A2 (pt) 2010-03-22 2016-07-05 Cempra Pharmaceuticals Inc formas cristalinas de um macrolídeo, e usos dos mesmos
PL2571506T3 (pl) 2010-05-20 2017-10-31 Cempra Pharmaceuticals Inc Sposoby sporządzania makrolidów i ketolidów oraz ich produktów pośrednich
AU2011278693B2 (en) * 2010-07-12 2015-02-19 Xellia Pharmaceuticals Aps Treatment of lung infections by administration of Tobramycin by aerolisation
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
CA2841272C (en) 2011-07-12 2019-01-15 Alan Bruce Montgomery Formulations of amikacin and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
MX2014011537A (es) 2012-03-27 2015-02-10 Cempra Pharmaceuticals Inc Formulaciones parenterales para la administracion de antibioticos macrolidos.
GB201208080D0 (en) 2012-05-09 2012-06-20 Norton Healthcare Ltd Tobramycin formulation
CA2883703C (en) 2012-09-04 2021-10-19 Eleison Pharmaceuticals, Llc Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
WO2014085526A1 (en) 2012-11-29 2014-06-05 Insmed Incorporated Stabilized vancomycin formulations
MX360905B (es) 2013-01-11 2018-11-21 Xellia Pharmaceuticals Aps Polimixinas, composiciones, metodos de preparacion y metodos de uso.
WO2014152326A1 (en) * 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
BR112015023670A2 (pt) 2013-03-15 2017-07-18 Cempra Pharmaceuticals Inc processo para preparar um composto
PL3142643T3 (pl) * 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
EP3166960B1 (en) 2014-07-09 2019-08-07 Xellia Pharmaceuticals ApS Low substituted polymyxins and compositions thereof
PT3200762T (pt) 2014-10-03 2019-05-28 Xellia Pharmaceuticals Aps Dispositivo de inalação
KR102433278B1 (ko) 2014-10-03 2022-08-16 셀리아 파마슈티칼즈 에이피에스 조성물
US10617703B2 (en) 2014-12-10 2020-04-14 Cmpd Licensing, Llc Compositions and methods for treating an infection
US10898491B2 (en) 2015-12-18 2021-01-26 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11690815B2 (en) 2015-08-05 2023-07-04 Cmpd Licensing Llc Hyperkeratotic skin condition treatments and compositions
US11278590B2 (en) 2015-08-05 2022-03-22 Cmpd Licensing, Llc Compositions and methods for treating nail infections
US11446236B2 (en) 2015-08-05 2022-09-20 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US10898455B2 (en) 2016-01-07 2021-01-26 Cmpd Licensing, Llc Urea cream formulations
US9999604B2 (en) 2016-11-17 2018-06-19 Cmpd Licensing, Llc Compounded solutions of diclofenac and lidocaine and methods
US10525025B2 (en) 2016-11-17 2020-01-07 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
EP3773505A4 (en) 2018-03-30 2021-12-22 Insmed Incorporated PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
AU2019262117C1 (en) 2018-05-02 2024-12-05 Insmed Incorporated Methods for the manufacture of liposomal drug formulations
WO2020163416A1 (en) * 2019-02-05 2020-08-13 Mylan Inc Devices and methods for tobramycin inhalation treatment

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993223A (en) 1974-07-25 1976-11-23 American Home Products Corporation Dispensing container
US4502616A (en) 1982-01-04 1985-03-05 Health Care Concepts, Inc. Single use vial
GB8801655D0 (en) 1988-01-26 1988-02-24 Waverley Pharma Ltd Ampoules
ES2038445T3 (es) 1988-01-28 1993-07-16 Lameplast S.R.L. Tiras de ampollas para productos farmaceuticos, cosmeticos y otros.
GB8802349D0 (en) 1988-02-03 1988-03-02 Waverley Pharma Ltd Ampoule with luer
DE3916840A1 (de) 1988-09-21 1990-03-29 Bernd Hansen Ampulle
US5409125A (en) 1989-12-11 1995-04-25 Aktiebolaget Astra Unit dose container
CA2027690A1 (en) 1990-10-18 1992-04-19 Christian Laing Plastic ampul
FR2687066A1 (fr) 1992-02-06 1993-08-13 Oreal Ampoule autocassable.
US5508269A (en) 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5758637A (en) * 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US6083922A (en) 1996-04-02 2000-07-04 Pathogenesis, Corp. Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
AU778797B2 (en) 1998-12-17 2004-12-23 Novartis Vaccines And Diagnostics, Inc. Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic
SE9902627D0 (sv) * 1999-07-08 1999-07-08 Siemens Elema Ab Medical nebulizer
DE19953317C1 (de) 1999-11-05 2001-02-01 Pari Gmbh Inhalationsvernebler
US20030143162A1 (en) 2001-05-18 2003-07-31 Speirs Robert John Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics

Similar Documents

Publication Publication Date Title
JP2009269923A5 (enExample)
US10835512B2 (en) Methods of treating respiratory syncytial virus infections
JP2011520911A5 (enExample)
JP6429788B6 (ja) 化合物送達のためのデバイス
US20220304980A1 (en) Metered dosing compositions and methods of use of psychedelic compounds
JP5863641B2 (ja) 濃縮肥満細胞安定化用薬学的調合物
JP2010526837A5 (enExample)
JP2008044951A5 (enExample)
WO2012040228A3 (en) Aerosol composition for administering drugs
Cazzola et al. Inhaled medication: which device for which patient
JP2006508994A5 (enExample)
JP2013522295A5 (enExample)
JP6945614B2 (ja) 経鼻投与
JP2006508993A5 (enExample)
Keller et al. In-vivo data support equivalent therapeutic efficacy of a new tobramycin inhalation solution (150 mg/1.5 mL) administered by the eFlow® electronic nebuliser compared to TOBI® in the PARI LC PLUS®
RU75944U1 (ru) Аэрозольная форма лекарственного средства
Konstan et al. Safety and efficacy of tobramycin inhalation powder (TIP) in treating CF patients infected with Pseudomonas aeruginosa (Pa)
Geller et al. Treatment convenience and satisfaction of tobramycin inhalation powder (TIP) versus TOBI in cystic fibrosis (CF) patients
Wainwright et al. A double-blind, multinational, randomized, placebo-controlled trial evaluating aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis (CF), mild lung disease and P. aeruginosa (PA)
CN201036611Y (zh) 一种心脏急救药盒
CN104582690A (zh) 用于经鼻部施用的组合物
HK40091740A (zh) 用於治疗、改善或预防微生物感染的制造产品和方法
RU2008103666A (ru) Способ лечения острой аллергии и устройство для доставки лекарственного средства
EA201590323A1 (ru) Способ введения активных веществ в головной мозг
RU2015147233A (ru) Способы лечения, включающие эсликарбазепин или эсликарбазепина ацетат